Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Other Accumulated Expenses (2024 - 2026)

Updated

Translational Development Acquisition's Other Accumulated Expenses was $166,762 in Q2 2026, up 256.6% from $46,762 a year earlier and up 21.9% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Translational Development Acquisition came in at $106,762.

  • In earlier years, Other Accumulated Expenses was $2,000 in FY2024.
  • Per Business Quant data, TDACU's Other Accumulated Expenses in the three quarters before Q2 2026 was $136,762 (Q1 2026), $106,762 (Q4 2025) and $76,762 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 166,762.00
Mar 31, 2026 136,762.00
Dec 31, 2025 106,762.00
Sep 30, 2025 76,762.00
Jun 30, 2025 46,762.00
Mar 31, 2025 22,423.00
Dec 31, 2024 2,000.00
API Access

Translational Development Acquisition Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TDACU&period=max&api_key=YOUR_API_KEY